News J&J settles Ohio lawsuits for $20m as opioid litigation trai... Johnson & Johnson has managed to put opioid litigation in Ohio behind it with a $20 million settlement, saying that will
News FDA approves J&J's prostate cancer drug Erleada in new use, ... The FDA has approved Johnson & Johnson’s prostate cancer drug Erleada (apalutamide) for patients whose prostate cancer has spread.
News Janssen's MS pill outshines Sanofi's Aubagio in phase 3 tria... Johnson & Johnson’s Janssen unit has announced phase 3 results showing that its ponesimod tablet outperformed Sanofi’s Aubagio pill in adults with relapsing multiple sclerosis.
News Repligen builds in cell therapy with $1.5bn BioLife takeover Repligen has reached a deal to buy cell therapy specialist BioLife Solutions for $1.5bn, tapping into a market growing at breakneck speed.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
